Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BAX NYSE:BDX NYSE:BSX NYSE:MMM NYSE:SYK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBAXBaxter International$19.19+0.8%$17.48$15.73▼$32.04$9.83B0.628.26 million shs7.22 million shsBDXBecton, Dickinson and Company$147.76+1.0%$152.83$127.59▼$187.35$40.30B0.223.38 million shs1.29 million shsBSXBoston Scientific$57.71+1.0%$61.97$52.52▼$109.50$85.87B0.6217.85 million shs11.74 million shsMMM3M$152.69+0.7%$147.09$139.34▼$177.41$79.07B1.034.09 million shs3.21 million shsSYKStryker$316.39+0.9%$325.22$281.00▼$404.87$121.33B0.82.99 million shs1.89 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBAXBaxter International+0.75%+10.95%+4.89%-11.10%-36.93%BDXBecton, Dickinson and Company+0.90%+3.10%-5.20%-20.31%-14.71%BSXBoston Scientific+1.11%+9.59%-11.14%-22.58%-44.86%MMM3M+0.62%+4.37%+4.78%-8.51%+2.18%SYKStryker+0.93%+3.15%-4.02%-16.77%-16.74%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBAXBaxter International$19.19+0.8%$17.48$15.73▼$32.04$9.83B0.628.26 million shs7.22 million shsBDXBecton, Dickinson and Company$147.76+1.0%$152.83$127.59▼$187.35$40.30B0.223.38 million shs1.29 million shsBSXBoston Scientific$57.71+1.0%$61.97$52.52▼$109.50$85.87B0.6217.85 million shs11.74 million shsMMM3M$152.69+0.7%$147.09$139.34▼$177.41$79.07B1.034.09 million shs3.21 million shsSYKStryker$316.39+0.9%$325.22$281.00▼$404.87$121.33B0.82.99 million shs1.89 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBAXBaxter International+0.75%+10.95%+4.89%-11.10%-36.93%BDXBecton, Dickinson and Company+0.90%+3.10%-5.20%-20.31%-14.71%BSXBoston Scientific+1.11%+9.59%-11.14%-22.58%-44.86%MMM3M+0.62%+4.37%+4.78%-8.51%+2.18%SYKStryker+0.93%+3.15%-4.02%-16.77%-16.74%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBAXBaxter International 1.92Reduce$19.913.75% UpsideBDXBecton, Dickinson and Company 2.38Hold$184.8625.11% UpsideBSXBoston Scientific 2.93Moderate Buy$92.7160.63% UpsideMMM3M 2.42Hold$171.1712.10% UpsideSYKStryker 2.73Moderate Buy$395.4825.00% UpsideCurrent Analyst Ratings BreakdownLatest BDX, BSX, SYK, BAX, and MMM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2026BSXBoston Scientific Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$78.00 ➝ $75.005/18/2026MMM3M Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C+) ➝ Buy (B-)5/18/2026BSXBoston Scientific Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$77.005/18/2026BSXBoston Scientific Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$105.00 ➝ $68.005/18/2026BSXBoston Scientific BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$80.005/15/2026BAXBaxter International Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/13/2026BSXBoston Scientific Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Hold (C-)5/11/2026BDXBecton, Dickinson and Company Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)5/11/2026BDXBecton, Dickinson and Company BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$202.00 ➝ $204.005/8/2026BDXBecton, Dickinson and Company Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$157.00 ➝ $161.005/7/2026BDXBecton, Dickinson and Company Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price Target$215.00 ➝ $175.00(Data available from 5/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBAXBaxter International$11.24B0.88$5.73 per share3.35$11.65 per share1.65BDXBecton, Dickinson and Company$21.84B1.86$23.31 per share6.34$86.24 per share1.71BSXBoston Scientific$20.61B4.16$4.08 per share14.16$17.57 per share3.28MMM3M$24.95B3.19$10.75 per share14.20$6.35 per share24.05SYKStryker$25.27B4.80$17.05 per share18.56$59.94 per share5.28Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBAXBaxter International-$957M-$2.13N/A9.743.06-9.70%16.15%5.24%7/30/2026 (Estimated)BDXBecton, Dickinson and Company$1.68B$3.9537.4110.7410.355.33%15.37%7.11%8/6/2026 (Estimated)BSXBoston Scientific$2.90B$2.3924.1515.391.0517.29%19.17%10.77%7/29/2026 (Estimated)MMM3M$3.25B$5.1929.4216.312.1911.14%104.75%12.03%7/17/2026 (Estimated)SYKStryker$3.25B$8.6436.6219.031.9813.20%23.42%11.04%7/30/2026 (Estimated)Latest BDX, BSX, SYK, BAX, and MMM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q2 2026BDXBecton, Dickinson and Company$2.77$2.90+$0.13-$1.11$4.67 billion$4.71 billion4/30/2026Q1 2026BAXBaxter International$0.31$0.36+$0.05-$0.03$2.62 billion$2.70 billion4/30/2026Q1 2026SYKStryker$2.98$2.60-$0.38$1.93$6.34 billion$6.02 billion4/22/2026Q1 2026BSXBoston Scientific$0.7930$0.80+$0.0070$0.90$5.19 billion$5.20 billion4/21/2026Q1 2026MMM3M$1.98$2.14+$0.16$1.23$6.04 billion$6.00 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBAXBaxter International$0.040.21%-11.54%N/A N/ABDXBecton, Dickinson and Company$4.202.84%+5.65%106.33%53 YearsBSXBoston ScientificN/AN/AN/AN/AN/AMMM3M$3.122.04%-13.06%60.12%1 YearsSYKStryker$3.521.11%+7.58%40.74%32 YearsLatest BDX, BSX, SYK, BAX, and MMM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/6/2026SYKStrykerquarterly$0.881.2%6/30/20266/30/20267/31/20264/29/2026BAXBaxter Internationalquarterly$0.010.23%5/29/20265/29/20267/1/20264/28/2026BDXBecton, Dickinson and Companyquarterly$1.052.81%6/9/20266/9/20266/30/20265/12/2026MMM3Mquarterly$0.782.04%5/22/20265/22/20266/12/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBAXBaxter International1.431.851.23BDXBecton, Dickinson and Company0.620.940.55BSXBoston Scientific0.421.901.22MMM3M3.291.591.19SYKStryker0.622.111.25Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBAXBaxter International90.19%BDXBecton, Dickinson and Company86.97%BSXBoston Scientific89.07%MMM3M65.25%SYKStryker77.09%Insider OwnershipCompanyInsider OwnershipBAXBaxter International0.17%BDXBecton, Dickinson and Company0.40%BSXBoston Scientific0.34%MMM3M0.19%SYKStryker4.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBAXBaxter International37,500516.47 million515.59 millionOptionableBDXBecton, Dickinson and Company72,000275.54 million274.44 millionOptionableBSXBoston Scientific59,0001.49 billion1.48 billionOptionableMMM3M60,500521.57 million520.58 millionOptionableSYKStryker56,000383.36 million365.73 millionOptionableBDX, BSX, SYK, BAX, and MMM HeadlinesRecent News About These CompaniesGlobal Retirement Partners LLC Grows Stock Holdings in Stryker Corporation $SYKMay 23 at 5:40 AM | marketbeat.comFideuram Intesa Sanpaolo Private Banking S.P.A. Makes New Investment in Stryker Corporation $SYKMay 22 at 3:57 AM | marketbeat.comStryker Expands Peripheral Vascular Reach With Amplitude Deal And Undervalued SharesMay 21 at 10:55 PM | finance.yahoo.comRathbones Group PLC Grows Stock Position in Stryker Corporation $SYKMay 21 at 6:16 AM | marketbeat.comProShare Advisors LLC Acquires 5,047 Shares of Stryker Corporation $SYKMay 21 at 5:04 AM | marketbeat.comStryker Announces Chief Accounting Officer Retirement and SuccessorMay 20 at 5:51 PM | tipranks.comHarvest Portfolios Group Inc. Purchases 15,499 Shares of Stryker Corporation $SYKMay 20 at 5:41 AM | marketbeat.comPNC Financial Services Group Inc. Lowers Stock Position in Stryker Corporation $SYKMay 20 at 5:41 AM | marketbeat.comStryker Corporation $SYK Stock Position Increased by Atle Fund Management ABMay 20 at 3:10 AM | marketbeat.comStryker: Investors May Have Overreacted To Q1 WeaknessMay 20 at 2:51 AM | seekingalpha.comIs Wall Street Bullish or Bearish on Stryker Corporation Stock?May 20 at 2:31 AM | barchart.comResona Asset Management Co. Ltd. Trims Stock Holdings in Stryker Corporation $SYKMay 19, 2026 | marketbeat.comBioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech EcosystemMay 19, 2026 | businesswire.comStryker Corporation $SYK Shares Bought by AMF Tjanstepension ABMay 19, 2026 | marketbeat.comAVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy StudyMay 18, 2026 | businesswire.comPAHC or SYK: Which Is the Better Value Stock Right Now?May 18, 2026 | zacks.comRiverFront Investment Group LLC Sells 4,777 Shares of Stryker Corporation $SYKMay 18, 2026 | marketbeat.comIs There Now An Opportunity In Stryker (SYK) After Recent Share Price PullbackMay 17, 2026 | finance.yahoo.comThrivent Financial for Lutherans Increases Position in Stryker Corporation $SYKMay 17, 2026 | marketbeat.comStryker (NYSE:SYK) vs. Metastat (OTCMKTS:MTST) Financial AnalysisMay 17, 2026 | americanbankingnews.comDana Investment Advisors Inc. Sells 6,037 Shares of Stryker Corporation $SYKMay 17, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBDX, BSX, SYK, BAX, and MMM Company DescriptionsBaxter International NYSE:BAX$19.19 +0.16 (+0.84%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$19.16 -0.02 (-0.13%) As of 05/22/2026 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.Becton, Dickinson and Company NYSE:BDX$147.76 +1.51 (+1.03%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$147.64 -0.13 (-0.09%) As of 05/22/2026 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.Boston Scientific NYSE:BSX$57.71 +0.56 (+0.99%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$57.52 -0.19 (-0.33%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.3M NYSE:MMM$152.69 +1.09 (+0.72%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$152.58 -0.11 (-0.07%) As of 05/22/2026 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.3M Company provides diversified technology services in the United States and internationally. The company's Safety and Industrial segment offers industrial abrasives and finishing for metalworking applications; autobody repair solutions; closure systems for personal hygiene products, masking, and packaging materials; electrical products and materials for construction and maintenance, power distribution, and electrical original equipment manufacturers; structural adhesives and tapes; respiratory, hearing, eye, and fall protection solutions; and natural and color-coated mineral granules for shingles. Its Transportation and Electronics segment provides ceramic solutions; attachment/bonding products, films, sound, and temperature management for transportation vehicles; premium large format graphic films for advertising and fleet signage; light management films and electronics assembly solutions; packaging and interconnection solutions; semiconductor production materials; data centers solutions; and reflective signage for highway, and vehicle safety. The company's Consumer segment provides consumer bandages, braces, supports, and consumer respirators; home cleaning products; retail abrasives, paint accessories, car care DIY products, picture hanging, and consumer air quality solutions; and stationery products. It offers its products through e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers. 3M Company was founded in 1902 and is headquartered in Saint Paul, Minnesota.Stryker NYSE:SYK$316.39 +2.89 (+0.92%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$316.50 +0.11 (+0.03%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
